Cargando…

A phase IV, randomized, multicenter, open-label trial comparing efficacy and systemic exposure for a standard weight-based dose versus a fixed dose of plerixafor in combination with G-CSF in patients with Non-Hodgkin’s lymphoma weighing ≤70 kg

A randomized, multicenter, open-label study explored the effect of a fixed-dose (FD) of plerixafor versus the approved weight-based (WB) dose for the mobilization of hematopoietic stem cells (HSCs) in patients with non-Hodgkin’s lymphoma and a body weight of ≤70 kg. After mobilization with granulocy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuruvilla, John, Tzeng, Cheng-Hwai, Cho, Seok-Goo, Kim, Seok Jin, Tang, Jih-Luh, Su, Yaming, Wu, Jingyang, Vargo, Rita, Cheverton, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365372/ https://www.ncbi.nlm.nih.gov/pubmed/29895931 http://dx.doi.org/10.1038/s41409-018-0253-y

Ejemplares similares

Development and validation of a predictive model to guide the use of plerixafor in pediatric population
por: Sebastien, Bernard, et al.
Publicado: (2022)

Association Between Antimicrobial Prophylaxis With Double-Dose Cefuroxime and Surgical Site Infections in Patients Weighing 80 kg or More
por: Sommerstein, Rami, et al.
Publicado: (2021)

Plerixafor use for peripheral blood stem cell mobilization in Korea
por: Kim, Seok Jin, et al.
Publicado: (2013)

Size selection of the Ambu AuraOnce laryngeal mask in Chinese men weighing >70 kg: a pilot study
por: Chen, Jiahui, et al.
Publicado: (2021)

Simplified dolutegravir dosing for children with HIV weighing 20 kg or more: pharmacokinetic and safety substudies of the multicentre, randomised ODYSSEY trial
por: Bollen, Pauline D J, et al.
Publicado: (2020)

Diabetes Limits Stem Cell Mobilization Following G-CSF but Not Plerixafor
por: Fadini, Gian Paolo, et al.
Publicado: (2015)

Plerixafor
por: Slater, Susan
Publicado: (2012)

P1316: INCREASED EFFICACY OF INTERMEDIATE-DOSE ARAC+G-CSF COMPARED TO CY+G-CSF AND PLERIXAFOR+G-CSF AS A STEM CELL MOBILIZATION REGIMEN IN POOR MOBILIZERS WITH HEMATOLOGICAL MALIGNANCIES
por: Elkhova, Svetlana, et al.
Publicado: (2023)

Case Study in Refractory Non-Hodgkin's Lymphoma: Successful Treatment with Plerixafor
por: Azim, Hamdy Abdel, et al.
Publicado: (2011)

Plerixafor on-demand in association with low-dose cyclophosphamide and G-CSF in the mobilization of patients with multiple myeloma: High effectiveness, low toxicity, and affordable cost
por: Milone, Giuseppe, et al.
Publicado: (2020)

Effectiveness of Medium-Dose Intravenous Immunoglobulin (1 g/kg) in the Treatment of Kawasaki Disease
por: Yeo, Joong-Seok, et al.
Publicado: (2010)

Continuous renal replacement therapy in neonates weighing less than 3 kg
por: Sohn, Young Bae, et al.
Publicado: (2012)

Bone marrow necrosis in a patient with advanced Hodgkin's lymphoma after G-CSF and Plerixafor treatment during harvesting for autologous bone marrow transplantation: is it possible?
por: Khoshnaw, Najmaddin, et al.
Publicado: (2021)

Plerixafor in non-Hodgkin’s lymphoma patients: a German analysis of time, effort and costs
por: Hübel, Kai, et al.
Publicado: (2018)

Transfemoral Perimembranous Ventricular Septal Defect Device Closure in Infants Weighing ≤ 10 kg
por: Alshahrani, Dhafer, et al.
Publicado: (2023)

Robot-assisted resection of choledochal cysts in children weighing less than 6 kg
por: Jin, Yi, et al.
Publicado: (2022)

Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trial
por: Waalewijn, Hylke, et al.
Publicado: (2022)

FTO Biology and Obesity: Why Do a Billion of Us Weigh 3 kg More?
por: Cheung, Man-Ka Marcella, et al.
Publicado: (2011)

Safety and Efficacy of Radiofrequency Catheter Ablation for Tachyarrhythmia in Children Weighing Less Than 10 kg
por: Ozaki, Noriyasu, et al.
Publicado: (2017)

Long-term outcomes of mitral valve replacement in patients weighing less than 10 kg
por: Yuan, Haoyong, et al.
Publicado: (2021)

Bilateral mucinous ovarian carcinoma in a young female with tumor weighing 41.1 kg
por: Khoiwal, Kavita, et al.
Publicado: (2022)

A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndrome
por: McDermott, David H., et al.
Publicado: (2023)

1661. Evaluation of Cefazolin < 3 g vs. 3 g Treatment Doses for Cellulitis in Patients Who Weigh ≥ 120 kg within a Large, Community Health System
por: Gens, Krista, et al.
Publicado: (2022)

Dose banding – Weighing up benefits, risks and therapeutic failure
por: Duffull, Stephen
Publicado: (2022)

Clinical outcome of transcatheter closure of patent ductus arteriosus in small children weighing 10 kg or less
por: Park, Young A, et al.
Publicado: (2010)

Patent Ductus Arteriosus Closure in Prematurities Weighing Less than 1 Kg by Subaxillary Mini-thoracotomy
por: Cho, Jungsoo, et al.
Publicado: (2010)

Transvaginal natural orifice transluminal endoscopic surgery (vNOTES) hysterectomy for uterus weighing ≥1 kg
por: Wang, Xiaojuan, et al.
Publicado: (2020)

High-dose Versus Low-dose Cyclophosphamide in Combination with G-CSF for Peripheral Blood Progenitor Cell Mobilization
por: Ahn, Jin Seok, et al.
Publicado: (2005)

Adequate exposure of 50 mg dolutegravir in children weighing 20 to 40 kg outside of sub-Sahara Africa
por: Waalewijn, Hylke, et al.
Publicado: (2022)

Use of an adapted bronchoscope for peroral endoscopic myotomy in a pediatric patient weighing less than 10 kg
por: Robles-Medranda, Carlos, et al.
Publicado: (2023)

Clinical characteristics and outcomes of continuous renal replacement therapy performed on younger children weighing up to 10 kg
por: GÜN, Emrah, et al.
Publicado: (2023)

Leukemia cell mobilization with G-CSF plus plerixafor during busulfan-fludarabine conditioning in allogeneic stem cell transplantation
por: Konopleva, Marina, et al.
Publicado: (2015)

A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia
por: Uy, G L, et al.
Publicado: (2017)

Successful mobilization using a combination of plerixafor and G-CSF in pediatric patients who failed previous chemomobilization with G-CSF alone and possible complications of the treatment
por: Hong, Kyung Taek, et al.
Publicado: (2012)

Haemodialysing babies weighing <8 kg with the Newcastle infant dialysis and ultrafiltration system (Nidus): comparison with peritoneal and conventional haemodialysis
por: Coulthard, Malcolm G., et al.
Publicado: (2014)

Transcatheter closure of patent ductus arteriosus in children weighing 10 kg or less: Initial experience at Sohag University Hospital
por: Ali, Safaa, et al.
Publicado: (2016)

Pediatric split liver transplantation using a hyperreduced left lateral segment graft in an infant weighing 4 kg
por: Namgoong, Jung-Man, et al.
Publicado: (2020)

Dosing of Ertapenem in an Extreme Obesity: A Case Report of 250 kg Patient
por: Lass, Jana, et al.
Publicado: (2017)

Inflammatory findings on species extrapolations: humans are definitely no 70-kg mice
por: Leist, Marcel, et al.
Publicado: (2013)

Plerixafor for autologous CD34(+) cell mobilization
por: Salman, Huda, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_3lfmeco6fbmumaa2mgptpdvp2q